Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CorMedix Inc. - Common Stock
(NQ:
CRMD
)
7.030
-0.050 (-0.71%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CorMedix Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
CorMedix Inc (NASDAQ:CRMD) Exemplifies a High-Growth Stock Screen Methodology
↗
January 20, 2026
Via
Chartmill
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
↗
January 19, 2026
Via
MarketBeat
Nasdaq, S&P 500 Futures Pause Ahead Of Jobs Report, Trump Tariff Ruling: Why OPEN, INTC, NVDA, TLRY, CRMD, GLUE Are On Traders' Radar Today
↗
January 09, 2026
Via
Stocktwits
Topics
Government
Stocks
CorMedix Stock Rises After-Hours: CEO Locks In Chairman Seat, Bigger Paycheck And Rich Severance
↗
January 08, 2026
Joseph Todisco’s annual base salary increases to $750,000 from $665,000, effective Jan. 1.
Via
Stocktwits
Here are the top movers in Thursday's session.
↗
January 08, 2026
Via
Chartmill
CorMedix Stock Breaks Out To 2-Month High: Analysts Reset Price Targets After Blowout Q3 And Surging DefenCath Demand
↗
November 13, 2025
Via
Stocktwits
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
CRMD Stock Is The Talk Of The Town Today: What’s The Latest 2025 Revenue Forecast?
↗
October 20, 2025
Via
Stocktwits
Analyst Expectations For Cormedix's Future
↗
September 09, 2025
Via
Benzinga
Why Did CRMD Stock Crash 28% Today?
↗
January 08, 2026
CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data.
Via
Stocktwits
These stocks are gapping in today's session
↗
January 08, 2026
Via
Chartmill
CorMedix Inc (NASDAQ:CRMD): A Textbook Fit for a High-Growth Stock Screener
↗
December 29, 2025
CorMedix (CRMD) exemplifies a high-growth stock with explosive sales, strong earnings momentum, and robust profitability, fitting a proven investment framework.
Via
Chartmill
Why CorMedix Could be the Biopharma Name to Watch Early in 2026
↗
December 23, 2025
Via
MarketBeat
MarketBeat’s Top 5 Rated Small-Cap Stocks
↗
December 22, 2025
Via
MarketBeat
Why Is CorMedix Stock Rising Today?
↗
December 18, 2025
CorMedix said that its catheter lock solution showed fewer catheter-related bloodstream infections and secondary hospitalizations in adult dialysis patients in the interim study.
Via
Stocktwits
CorMedix Inc (NASDAQ:CRMD) Shows Explosive Growth Metrics in "Little Book" Screen
↗
December 08, 2025
CorMedix (CRMD) shows explosive sales & earnings growth, strong momentum, and a surprisingly low valuation, making it a top growth stock candidate.
Via
Chartmill
Talphera (TLPH) Q3 2025 Earnings Call Transcript
↗
November 13, 2025
Talphera (TLPH) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations
↗
November 12, 2025
CorMedix posts strong Q3 results with $104 million in revenue, higher DefenCath sales, and raises 2025 guidance following Melinta integration progress.
Via
Benzinga
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday
↗
November 12, 2025
Via
Benzinga
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance
↗
November 12, 2025
The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million.
Via
Stocktwits
Topics
Earnings
CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings: Revenue Beat Offsets EPS Miss
↗
November 12, 2025
CorMedix Inc. (CRMD) Q3 2025 earnings show a revenue beat of $104.3M, but an EPS miss. The stock rose in pre-market trading on strong sales growth.
Via
Chartmill
CorMedix Inc (NASDAQ:CRMD) Fulfills Key Growth Stock Criteria from The Little Book
↗
November 11, 2025
CorMedix (CRMD) excels in a proven growth stock strategy, showing massive sales growth, strong earnings momentum, and solid profitability metrics.
Via
Chartmill
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More
↗
November 10, 2025
Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle.
Via
Benzinga
Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 22, 2025
From
Halper Sadeh LLC
Via
Business Wire
Beyond The Numbers: 4 Analysts Discuss Cormedix Stock
↗
October 21, 2025
Via
Benzinga
CorMedix Inc (NASDAQ:CRMD) Fits a Proven Growth Strategy with Strong Fundamentals
↗
October 21, 2025
CorMedix Inc. fits a proven growth investing strategy with explosive revenue growth, soaring profits, and strong analyst revisions, signaling high potential.
Via
Chartmill
CorMedix Inc (NASDAQ:CRMD) Identified as a Top Growth Stock Candidate
↗
September 29, 2025
CorMedix Inc (CRMD) identified as a top growth stock using Louis Navellier's strategy, showing explosive revenue growth, soaring earnings estimates, and strong profitability.
Via
Chartmill
CorMedix Inc (NASDAQ:CRMD) Embodies a Proven Growth Investing Strategy
↗
September 08, 2025
CorMedix (CRMD) excels in Louis Navellier's growth strategy with massive revenue growth, soaring earnings, and high ROE, making it a top stock to watch.
Via
Chartmill
10 Health Care Stocks Whale Activity In Today's Session
↗
September 02, 2025
Via
Benzinga
CORMEDIX INC (NASDAQ:CRMD) – A High-Growth Stock Aligned with Louis Navellier’s Investment Strategy
↗
August 18, 2025
Discover how CORMEDIX INC (CRMD) aligns with Louis Navellier’s growth investing strategy, showcasing strong earnings momentum, rapid revenue growth, and high ROE for potential stock gains.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
